AgingResearch.NewsJoin free

Xeris Pharmaceuticals

Organisation

Trials

  • NCT05823012

    Phase 2, Completed, 46 people, 21 Apr 2023

  • NCT03770637

    Phase 2, Completed, 14 people, 10 Dec 2018

  • NCT03738865

    Phase 3, Completed, 132 people, 13 Nov 2018

  • NCT03490942

    Phase 2, Terminated, 49 people, 6 Apr 2018

  • NCT03439072

    Phase 3, Completed, 81 people, 20 Feb 2018

  • NCT03255629

    Collaborator, Phase 1/2, Completed, 18 people, 21 Aug 2017

  • NCT03091673

    Phase 3, Completed, 31 people, 27 Mar 2017

  • NCT02937558

    Phase 2, Completed, 5 people, 18 Oct 2016

  • NCT02733588

    Phase 2, Completed, 8 people, 11 Apr 2016

  • NCT02660242

    Collaborator, Phase 2, Completed, 16 people, 21 Jan 2016

  • NCT02656069

    Phase 3, Completed, 80 people, 14 Jan 2016

  • NCT02423980

    Phase 2, Completed, 7 people, 22 Apr 2015

  • NCT02411578

    Collaborator, Phase 2, Completed, 26 people, 8 Apr 2015

  • NCT02081014

    Phase 2, Completed, 13 people, 7 Mar 2014

  • NCT02081001

    Phase 2, Completed, 19 people, 7 Mar 2014

Papers